Coronavirus vaccine updates in India: 10,500 people get an injection in Gujarat, around 6,000 missed, authorities say

Coronavirus Vaccine India LATEST updates: Day one of COVID-19 The inoculation campaign went smoothly in Gujarat on Saturday with around 10,500 health workers, up from 16,000 expected, receiving the vaccine dose. “Reports are coming in from different centers, and it’s been good everywhere, without a problem,” said Dr. Nayan Jani, a state immunization official.

More than 16,000 people were scheduled to receive the jab during the day, but some recipients did not show up, he said. The campaign was carried out in 161 centers.

The number of people who tested positive for the new British variant of SARS-CoV-2 in the country rose to 116, the Union Health Ministry said on Saturday. “The total number of people infected with the new UK genome variant is 116,” the ministry said.

All of these people have been kept in single-room isolation in health facilities designated by the respective state governments, the ministry had previously said.

“Their close contacts have also been quarantined. A full contact tracing has been initiated for fellow travelers, family contacts and others. Genome sequencing is being carried out on other specimens,” the ministry said.

The Union Health Ministry held a press conference at the end of the first day of the nationwide vaccination campaign and said that no cases of post-vaccination hospitalization were reported until 7pm on Saturday.

The Health Ministry said provisional data from Saturday night showed that 1,65,714 beneficiaries were vaccinated at 3,351 sites across the country on the first day of the COVID-19 vaccination campaign. At a press conference, the Additional Health Secretary, M Agnani, added that 16,755 people participated in the campaign.

The number of people who tested positive for the new British variant of SARS-CoV-2 in the country rose to 116, the Union Health Ministry said on Saturday. “The total number of people infected with the new UK genome variant is 116,” the ministry said.

All of these people have been kept in single-room isolation in health facilities designated by the respective state governments, the ministry had previously said.

“Their close contacts have also been quarantined. A full contact tracing has been initiated for fellow travelers, family contacts and others. Genome sequencing is being carried out on other specimens,” the ministry said.

Bharat Biotech, which has received a government purchase order for the supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company will pay compensation to recipients in the event of serious adverse effects after receiving the antidote.

A consent form to be signed by vaccine recipients read: “In the event of any adverse event or serious adverse event, you will be provided with a recognized standard of medical care at government-designated and authorized centers and hospitals.”

“Compensation for a serious adverse event will be paid by the sponsor (BBIL) in the event that SAE is shown to be causally related to the vaccine,” the form said.

The Resident Physicians Association (RDA) at Ram Manohar Lohia Hospital in Delhi requested the medical superintendent to vaccinate them with the Oxford-AstraZeneca. COVID-19 Covishield vaccine.

In a letter to the medical superintendent, the association said resident physicians were “a little concerned” about Bharat Biotech’s Covaxin and that they might not participate in the mass immunization campaign, thus defeating the purpose of the exercise that began in the country. Saturday. .

“We have come to know that the COVID-19 The hospital is conducting a vaccination campaign today. Covaxin manufactured by Bharat Biotech is preferred in our hospital over Covishield manufactured by Serum Institute Residents are a little concerned about the lack of a complete test in the case of Covaxin and may not participate in large quantities, defeating the purpose of the vaccination. We request that you vaccinate us with Covishield, which has completed all stages of testing prior to implementation, “the letter read.

Maharashtra Health Minister Rajesh Tope said the state has received 10 lakh of vaccine doses, or 60 percent of allocated stocks, so far and the remaining doses will be available in the next 10 days.

Speaking to journalists after attending the vaccination campaign in Jalna, Tope said that at least 8 lakh of health workers have registered for this program, and for this, the state needs 7.5 lakh of additional doses of the vaccine.

“Although the state has received 60 percent of the vaccine stock it needs, the remaining shipment will be available in the next 10 days,” said the minister. “Maharashtra needs a 17.50 lakh dose of coronavirus vaccine, as 8 lakh healthcare workers have registered for the program on the CoWIN app. We have received 10 lakh doses and still need 7.5 lakh more. “

Union Health Minister Harsh Vardhan responded to congressional leader Manish Tewari’s quote asking why politicians and government officials were not vaccinated according to the procedure in other countries. Vardhan criticized Tewari, saying that he and Congress are “passionate about spreading rumors.”

In response, Tewari warned the government not to “hide behind vaccine nationalism.”

In a series of tweets on Saturday, Union Interior Minister Amit Shah praised the scientists and ‘ COVID-19 warriors’ and said: “India is one of the few countries that has won the leadership to end the greatest crisis against humanity.”

“This ‘Made in India’ vaccine represents the determination of self-sufficient India. On this historic day, I bow to all of our Crown warriors,” he added.

The director of the Serum Institute of India, Adar Poonawalla, took a photo of the COVID-19 Covishield vaccine.

Delhi Chief Minister Arvind Kejriwal said experts have said the vaccine against COVID-19 it is safe and people should not heed rumors.

Punjab’s Chief Minister Captain Amarinder Singh said he has written to Prime Minister Narendra Modi asking for free vaccines for lower income groups.

Following the launch of a nationwide vaccination campaign, Health Minister Dr Harsh Vardhan said the vaccine will work as ‘sanjeevani’ against COVID-19 .

The first dose of coronavirus The vaccine was administered to a sanitation worker at AIIMS Delhi.

Prime Minister Narendra Modi said that the vaccines available in India are much cheaper than options in other countries, adding that they do not need to be stored at extremely low temperatures.

Stating that work on other vaccines is progressing at a rapid pace, Prime Minister Narendra Modi praised the development and launch of two Made In India vaccines in a short period of time.

A total of 3,006 session sites in all states and territories of the Union will be virtually connected during the 10:30 AM launch by Prime Minister Narendra Modi and around 100 beneficiaries will be vaccinated at each session site.

One day before a mass vaccination campaign across the country against coronavirus is scheduled to start, Union Health Minister Harsh Vardhan said on Friday that the step is “probably the beginning of the end” of COVID-19 .

However, speaking on the 146th day of the founding of the Indian Meteorological Department (IMD), he warned that even if the vaccination campaign is on, there should be no lowering of guard and people should continue COVID-19 appropriate behavior.

“Tomorrow is an important day … it is the last phase of the battle against coronavirus . I mean, this is probably the beginning of the end of COVID now, which will start tomorrow, “said Vardhan, who is also Minister for Science and Technology and Earth Sciences.

Prime Minister Narendra Modi to Launch India COVID-19 vaccination campaign on January 16 via videoconference.

This will be the largest vaccination program in the world covering the entire country far and wide and all preparations have been made to start the program.

The vaccination program is based on principles of priority groups to be vaccinated first. Healthcare workers in both the government and private sectors, including Integrated Child Development Services (ICDS) workers, will receive the vaccine during this phase.

The Comptroller General of Drugs of India (DCGI) had earlier this month approved Oxford COVID-19 the Covishield vaccine, manufactured by the Serum Institute, and Bharat Biotech’s Covaxin, developed indigenously for restricted emergency use in the country, paving the way for a massive inoculation campaign.